Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of
INSM1
in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma
Authors
Keywords
-
Journal
LARYNGOSCOPE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-14
DOI
10.1002/lary.29554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56
- (2020) Rie Sakakibara et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature
- (2020) Johan Staaf et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Insulinoma‐associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors
- (2020) David Kim et al. CANCER CYTOPATHOLOGY
- The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas
- (2020) BillyShui‐wun Lai et al. ONCOLOGIST
- Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors
- (2020) B. Mahalakshmi et al. CELLULAR ONCOLOGY
- CD56 Expression Is Associated with Biological Behavior of Pancreatic Neuroendocrine Neoplasms
- (2020) Xin Chen et al. Cancer Management and Research
- Insulinoma-associated-1: From neuroendocrine tumor marker to cancer therapeutics
- (2019) Chiachen Chen et al. MOLECULAR CANCER RESEARCH
- A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases
- (2019) Cem Leblebici et al. Annals of Diagnostic Pathology
- Update on Neuroendocrine Carcinomas of the Larynx
- (2019) Carolina Strosberg et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors
- (2018) Lisa M. Rooper et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Systemic therapy in non-conventional cancers of the larynx
- (2018) Elaine Tan et al. ORAL ONCOLOGY
- Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients
- (2018) Yorihiko Takase et al. CYTOPATHOLOGY
- Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56
- (2018) Katharina Kriegsmann et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Immunophenotypic Heterogeneity of Primary Sinonasal Melanoma With Aberrant Expression of Neuroendocrine Markers and Calponin
- (2010) Hwajeong Lee et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started